Hosted on MSN
Barrett’s esophagus and the silent cancer risk
Barrett’s esophagus is a condition where the esophageal lining changes after long-term acid reflux, raising the risk of esophageal adenocarcinoma. New research confirms it as the starting point for ...
Michael S. Smith, MD, MBA, Medical Director of the Esophageal Program at the Temple University School of Medicine said: Ablation therapy for Barrett’s esophagus is the most powerful tool available to ...
Hosted on MSN
Genetic link to Barrett's esophagus discovered, offering new hope for esophageal cancer patients
Case Western Reserve University researchers have made a significant breakthrough in understanding Barrett's esophagus, a precancerous condition that dramatically increases the risk of developing ...
New research provides compelling evidence that Barrett’s esophagus underlies all cases of esophageal adenocarcinoma, even ...
The Barrett's Esophagus Center at Baylor Medicine in Houston, Texas, offers the latest screening and therapeutic techniques for managing GERD and Barrett's Esophagus. Led by Drs. Mohamed Othman, ...
SAN DIEGO—Gastroenterologists have debated the best course of action for patients with Barrett’s esophagus for decades. Which is better for detecting early malignancy and preventing progression to ...
The study population consisted of patients who were referred to the endoscopy unit between March and July 2001. A total of 395 patients who were admitted to the endoscopy unit were enrolled into the ...
A team led by researchers at Baylor College of Medicine and Washington University School of Medicine has shed light on the process that drives Barrett’s esophagus formation. This condition affects the ...
Castle Biosciences’ TissueCypher® test can offer patients with Barrett’s esophagus a clearer picture of their risk of developing esophageal cancer. Esophageal cancer is a killer. It’s the eighth most ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received assay ...
Massachusetts-based Lumicell has received a Phase I Small Business Innovation Research contract from the National Cancer Institute (NCI), for development of an endoscopic imaging system for diagnosis ...
IN THIS MORNING’S MEDICAL ALERT, APRIL IS ESOPHAGEAL AWARENESS MONTH. AND HERE TO TELL US ABOUT THE DISEASE, WHO IT AFFECTS, AND THE WARNING SIGNS IS PRESIDENT AND CEO OF THE ESOPHAGEAL CANCER ACTION ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results